Recent corporate updates from Profound Medical highlight record quarterly purchase orders, growing sales pipelines for its TULSA-PRO systems, and continued expansion of insurance reimbursement coverage across major healthcare plans. Additionally, the company has reported positive clinical trial data from its ongoing studies, expanded its international hospital partnerships, and advanced collaborative software integration initiatives designed to streamline magnetic resonance imaging workflow procedures.